Daiichi Sankyo Company, Limited (TYO:4568)

Daiichi Sankyo Company Revenue

Daiichi Sankyo Company had revenue of 592.49B JPY in the quarter ending September 30, 2026, with 18.32% growth. This brings the company's total for the last twelve months to 2.31T, up 16.98% year-over-year. In the fiscal year ending March 31, 2026, Daiichi Sankyo Company had annual revenue of 2.12T with 12.55% growth. That makes Daiichi Sankyo Company the 1,061st largest company in the world by revenue and 98th in Japan.

• Revenue (ttm): 2.31T
• Revenue Growth: +16.98%
• P/S Ratio: 2.28
• Revenue / Employee: 114.77M
• Employees: 20,171
• Market Cap: 5.30T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Prescription Drugs 2.03T 95.6%
• Healthcare (OTC) Products 90.78B 4.3%
• Other 2.72B 0.1%

By Geography

Chart

• United States 749.40B 35.3%
• Japan 580.11B 27.3%
• Europe 497.38B 23.4%
• Other Regions 296.16B 13.9%

Fiscal year ended Mar 31, 2026 See the full Daiichi Sankyo Company breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.12T	236.79B	12.55%
Mar 31, 2025	1.89T	284.57B	17.77%
Mar 31, 2024	1.60T	323.21B	25.28%
Mar 31, 2023	1.28T	233.59B	22.36%
Mar 31, 2022	1.04T	82.38B	8.56%

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error